Myocardial amyloid deposition in patients aged over 85 years with heart failure and preserved ejection fraction
10.3760/cma.j.issn.0253-3758.2018.06.006
- VernacularTitle: 85岁及以上射血分数保留的心力衰竭患者心肌淀粉样物质沉积分析
- Author:
Yingying LI
1
;
Wanrong ZHU
;
Ke CHAI
;
Jiefu YANG
;
Fang FANG
;
Shurong HE
;
Chongqing YANG
;
Hua WANG
Author Information
1. Department of Cardiology, Beijing Hospital, National Center of Gerontology, Beijing 100730, China
- Publication Type:Journal Article
- Keywords:
Heart failure;
Myocardium;
Amyloidosis;
Autopsy;
Cardiac fibrosis
- From:
Chinese Journal of Cardiology
2018;46(6):438-443
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To determine the frequency and extent of left ventricular amyloid deposition in patients aged over 85 years with heart failure and preserved ejection fraction (HFpEF).
Methods:A total of 43 patients aged 85 to 100 years old were enrolled in this study based on the autopsy database of Beijing Hospital from February 1, 2003 to October 31, 2016. The frequency and extent of left ventricular amyloid deposition and myocardial fibrosis were determined in left ventricular specimens from patients with antemortem diagnosis of HFpEF without clinically apparent amyloid (n=28) and from control subjects (n=15) post Congo red staining and Masson's trichrome staining. Kappa test was used to evaluate the consistency of the myocardial amyloidosis and fibrosis.
Results:The heart weight of the patients in HFpEF group and in control group were similar((452.7±107.7)g vs. (415.0±70.8)g, t=-1.218, P=0.23)). Positive Congo-red staining was found in 24 examples (24/28) in HFpEF group and 5 examples (5/15) in the control group; severe amyloid deposition was found in 7 examples (7/28) in HFpEF group, but not in the control group. Amyloid deposition was more severe in HFpEF group than in control group (χ2=12.205, P<0.01). Masson's trichrome staining evidenced moderate to severe fibrosis in 19 cases (19/28) in HFpEF group and 8 cases (8/15) in control group (χ2=1.019, P=0.35). A consistent evaluation of the degree of myocardial fibrosis and the degree of myocardial amyloid deposition in all selected participants was performed and results showed that these two parameters were not consistent (Kappa value=0.2, P=0.820).
Conclusion:Amyloid deposition is common in the elderly patients with heart failure and preserved ejection fraction, suggesting that myocardial amyloidosis may be related to the development of HFpEF. There is no significant correlation between myocardial amyloidosis and myocardial fibrosis in this cohort.
